I share your thoughts on this one Doug but there's many an Australian biotech company that has been put up as having outstanding potential to deliver on science and investor return and there's almost as many fallen by the wayside, a number near the last hurdle. I've learnt by bitter experience biotech investing is a game fraught with danger and I'm a person not particularly adverse to risk.
really really good, page-15
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.005(1.33%) |
Mkt cap ! $467.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 40.0¢ | 37.5¢ | $1.204M | 3.107M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 99908 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 16868 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |